Ra Capital Management, L.P. 89bio, Inc. Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in 89bio, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 14,175,398 shares of ETNB stock, worth $121 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
14,175,398Holding current value
$121 Million% of portfolio
1.71%Shares
9 transactions
Others Institutions Holding ETNB
# of Institutions
157Shares Held
107MCall Options Held
65KPut Options Held
1.2M-
Janus Henderson Group PLC London, X013.3MShares$113 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.03MShares$68.4 Million2.69% of portfolio
-
Bvf Inc San Francisco, CA7.57MShares$64.4 Million1.85% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$62.8 Million0.99% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$59.7 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $396M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...